Disruption of the ACE2/Ang (1-7)/Mas receptor axis in COVID-19 patients, therefore, appears to be intimately involved in SARS-CoV-2-induced myocardial injury and this is supported by the decreased myocardial ACE2 expression detected in post-mortem heart samples [77,98]. This evidence concerns the gene ACE2 and COVID-19.